Item 2.02 Results of Operations and Financial Condition.

On January 10, 2023, Inogen, Inc. (the "Company") issued a press release reporting preliminary, unaudited revenue results for the fourth quarter and full year ended December 31, 2022. The amounts included in the press release are preliminary, have not been audited and are subject to change upon completion of the Company's audited financial statements for the year ended December 31, 2022. Additional information and disclosures would be required for a more complete understanding of the Company's financial position and results of operations as of December 31, 2022. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report 8-K.

Item 7.01. Regulation FD Disclosure.

Investor Conference

The chief executive officer and chief financial officer of the Company will participate in the 2023 J.P. Morgan Healthcare Conference, which began on Monday, January 9, 2023. The chief executive officer is scheduled to present at the conference on Wednesday, January 11, 2023, at 10:30 a.m. Pacific Time. During the conference and in separate sessions with analysts and investors, the Company's officers will refer to an updated slide presentation, which the Company has posted to the Investor Relations page on the Company's website at www.inogen.com. Interested parties can access the live audio webcast of this conference presentation from the Events section of the Investor Relations page on the Company's website at www.inogen.com. The information posted on or that can be accessed through Inogen's website, including Inogen's updated corporate presentation, is not incorporated by reference herein, and the inclusion of Inogen's website address is an inactive textual reference only.

The information furnished in this Current Report on Form 8-K under Items 2.02 and 7.01 and the exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



Exhibit    Description

 99.1       Press Release, dated January 10, 2023
  104     The cover page of this Current Report on Form 8-K, formatted in Inline XBRL

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses